Subcutaneous Injection Performance in Yucatan Miniature Pigs with and without Human Hyaluronidase and Auto-injector Tolerability in Humans
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Subcutaneous Injection Performance in Yucatan Miniature Pigs with and without Human Hyaluronidase and Auto-injector Tolerability in Humans
Authors
Keywords
-
Journal
AAPS PHARMSCITECH
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-07
DOI
10.1208/s12249-020-01880-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Subcutaneous Site-of-Absorption Study with the Monoclonal Antibody Tocilizumab in Minipigs: Administration Behind Ear Translates Best to Humans
- (2020) Wolfgang F. Richter et al. AAPS Journal
- ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20
- (2019) Kenneth W. Locke et al. DRUG DELIVERY
- A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers
- (2019) Agnès Portron et al. CLINICAL THERAPEUTICS
- Hold the device against the skin: the impact of injection duration on user’s force for handheld autoinjectors
- (2019) Andreas Schneider et al. Expert Opinion on Drug Delivery
- Validation of the Vectra H1 portable three-dimensional photogrammetry system for facial imaging
- (2018) L. Camison et al. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities
- (2018) Beate Bittner et al. BIODRUGS
- Subcutaneous drug delivery: An evolving enterprise
- (2017) Graham B. Jones et al. Science Translational Medicine
- Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)
- (2016) M. Rummel et al. ANNALS OF ONCOLOGY
- Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase
- (2016) Christopher C. DuFort et al. BIOPHYSICAL JOURNAL
- Subcutaneous Injection Volume of Biopharmaceuticals—Pushing the Boundaries
- (2016) Roman Mathaes et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The Miniature Swine as a Model in Experimental and Translational Medicine
- (2016) Alain Stricker-Krongrad et al. TOXICOLOGIC PATHOLOGY
- Time Savings with Rituximab Subcutaneous Injection versus Rituximab Intravenous Infusion: A Time and Motion Study in Eight Countries
- (2016) Erwin De Cock et al. PLoS One
- Natural and Sun-Induced Aging of Human Skin
- (2015) L. Rittie et al. Cold Spring Harbor Perspectives in Medicine
- Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study
- (2014) X. Pivot et al. ANNALS OF ONCOLOGY
- Time Savings With Transtuzumab Subcutaneous (SC) Injection Verse Trastuzumab Intravenous (IV) Infusion: A Time and Motion Study in 3 Russian Centers
- (2014) E. De Cock et al. VALUE IN HEALTH
- The Minipig as Nonrodent Species in Toxicology—Where Are We Now?
- (2012) Niels Christian Ganderup et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2-Positive Breast Cancer
- (2012) Chris Wynne et al. JOURNAL OF CLINICAL PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started